AMG-337

N/A

Report date: 2023/12/07 20:00:52
NME

Base Information

Drug NameAMG-337
Drug Alias NameAMG-337
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHepatocyte growth factor receptor inhibitors
TargetsHepatocyte growth factor receptor
Therapy Area/IndicationsEsophageal adenocarcinomaSolid tumoursStomach Neoplasms +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumCanada +[20] 
CombinationsNo
Global Highest StatusIND
Highest Status in ChinaIND
Originator CompaniesAmgen Inc
China Registration ClassN/A

Develop Information

Active CompaniesNantworksAmgen IncAmgen Biotechnology Consultation (Shanghai) Co Ltd +[4] 
Inactive CompaniesNational Cancer InstituteNantpharma Llc
Active IndicationsEsophageal adenocarcinomaStomach Neoplasms
Inactive IndicationsSolid tumoursEsophageal NeoplasmsGastrointestinal Neoplasms +[5] 

Other Information

ATC CodeN/A
Related LinksN/A